| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| Santarus Shares Up 87.3% Since SmarTrend's Buy Recommendation | | - | SmarTrend |
| 18.05.
| Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting | | 54 | Business Wire |
| Santarus,
Inc. (NASDAQ: SNTS) today announced that safety and efficacy data
from a Phase III, double-blind, multicenter, placebo-controlled 12 month
extended use...
Mehr lesen zu:
Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting | |
| 16.05.
| Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript) | | - | Seeking Alpha |
| 09.05.
| Santarus' CEO Discusses Q1 2012 Results - Earnings Call Transcript | | - | Seeking Alpha |
| 08.05.
| Santarus Reports First Quarter 2012 Financial Results | | 22 | Business Wire |
| Total revenues of $45.9 million more than double compared with the
prior year period
Affirms 2012 financial outlook
Santarus, Inc....
Mehr lesen zu:
Santarus Reports First Quarter 2012 Financial Results | |
| 07.05.
| Santarus to Present at Bank of America Merrill Lynch 2012 Health Care Conference | | 61 | Business Wire |
| Santarus,
Inc. (NASDAQ: SNTS) today announced that Wendell Wierenga, Ph.D.,
executive vice president, research and development, will make a
presentation at the...
Mehr lesen zu:
Santarus to Present at Bank of America Merrill Lynch 2012 Health Care Conference | |
| 26.04.
| Recent 52-Week High Exceeded in Shares of Santarus | | - | SmarTrend |
| 26.04.
| Santarus to Hold First Quarter 2012 Financial Results Conference Call on May 8 | | 34 | Business Wire |
| Santarus, Inc. (NASDAQ: SNTS) today announced that it will release first
quarter 2012 financial results after market close on Tuesday, May 8,
2012. Santarus management...
Mehr lesen zu:
Santarus to Hold First Quarter 2012 Financial Results Conference Call on May 8 | |
| 25.04.
| 92.4% Return Seen to Date on SmarTrend Santarus Call | | 1 | SmarTrend |
| 12.04.
| Possible Bullish Inside Day Candle Pattern Detected for Santarus | | - | SmarTrend |
| 11.04.
| Shares of Santarus Rank the Highest in Terms of P/E Ratio in the Pharmaceuticals Industry | | - | SmarTrend |
| 10.04.
| Santarus Appoints Alessandro E. Della Chà and Matthew W. Strobeck to Board of Directors | | 47 | Business Wire |
| Santarus, Inc. (NASDAQ: SNTS) today announced the appointment of
Alessandro E. Della Chà and Matthew W. Strobeck, Ph.D., to the company's
board of directors, increasing...
Mehr lesen zu:
Santarus Appoints Alessandro E. Della Chà and Matthew W. Strobeck to Board of Directors | |
| 01.04.
| Shares of Santarus Rank the Highest in Terms of Projected Earnings Growth in the Pharmaceuticals Industry | | - | SmarTrend |
| 28.03.
| Santarus to Present at 11th Annual Needham Healthcare Conference | | 57 | Business Wire |
| Santarus, Inc. (NASDAQ: SNTS) today announced that Gerald T. Proehl,
president and chief executive officer, will make a presentation at the 11th
Annual Needham Healthcare...
Mehr lesen zu:
Santarus to Present at 11th Annual Needham Healthcare Conference | |
| 05.03.
| Santarus Reports Fourth Quarter and Full Year 2011 Financial Results | | 53 | Business Wire |
| 2011 fourth quarter revenues of $42.6 million grew 65% over prior
year period
2011 revenues totaled $118.8 million with net income of $4.7 million
...
Mehr lesen zu:
Santarus Reports Fourth Quarter and Full Year 2011 Financial Results | |
| 29.02.
| Santarus to Present at March Investment Conferences | | 34 | Business Wire |
| Santarus, Inc. (NASDAQ: SNTS) today announced that Gerald T. Proehl,
president and chief executive officer, will make presentations at the
following investment conferences:
...
Mehr lesen zu:
Santarus to Present at March Investment Conferences | |
| 27.02.
| Santarus to Hold Fourth Quarter and Full Year 2011 Financial Results Conference Call on March 5 | | 31 | Business Wire |
| Santarus, Inc. (NASDAQ: SNTS) today announced that it will release
fourth quarter and full year 2011 financial results after market close
on Monday, March 5, 2012. Santarus...
Mehr lesen zu:
Santarus to Hold Fourth Quarter and Full Year 2011 Financial Results Conference Call on March 5 | |
| 22.02.
| UPDATE 1-Santarus, Depomed settle dispute with Lupin | | - | Reuters.com |
| 22.02.
| Santarus (SNTS), Depomed (DEPO) Enter Settement w/ Lupin Over GLUMETZA | | - | StreetInsider.com |
| 22.02.
| Santarus and Depomed Announce Settlement with Lupin of GLUMETZA Patent Litigation | | 68 | Business Wire |
| Santarus, Inc. (NASDAQ:SNTS) and Depomed, Inc. (NASDAQ:DEPO) today
announced that they have entered into a settlement agreement with Lupin
Ltd. and its subsidiary, Lupin...
Mehr lesen zu:
Santarus and Depomed Announce Settlement with Lupin of GLUMETZA Patent Litigation | |
